Alung Technologies: Clinical Trials

7 trials sponsored by Alung Technologies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown, 1 withdrawn. 5 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Terminated 1
Phase 31Withdrawn 1

Follow Alung Technologies: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD
Hemolung Respiratory Assist System, Invasive mechanical ventilation - Acute Exacerbation of COPD
Not applicableTerminatedAlung Technologies1132018-02-182022-10-14
Physiological Study of Minimally Invasive ECCO2R in Exacerbations of COPD Requiring Invasive Mechanical Ventilation
extracorporeal CO2 removal (Hemolung device) - Chronic Obstructive Pulmonary Disease
Not applicableCompletedAssistance Publique - Hôpitaux de Paris122016-07-012018-02-27
ECCO2R as an Adjunct to NIV in AECOPD
NIV, ECCO2R - Chronic Obstructive Pulmonary Disease
Not applicableCompletedGuy's and St Thomas' NHS Foundation Trust212015-12-012021-08-11
Hemolung RAS Registry Program
Acute Hypercapnic Respiratory Failure
UnknownAlung Technologies992013-04-012019-01-28
Feasibility Study of the Hemolung Respiratory Assist System (Germany)
Hemolung Respiratory Assist System - Hypercapnic Respiratory Failure, COPD, ARDS
Not applicableCompletedAlung Technologies212009-12-012019-09-30
Feasibility Study of the Hemolung Respiratory Assist System
Hemolung Respiratory Assist System - Hypercapnic Respiratory Failure, COPD
Not applicableCompletedAlung Technologies22009-10-012017-08-10
Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
Hattler Respiratory Assist Catheter - Emphysema, Acute Respiratory Distress Syndrome
Phase 3WithdrawnAlung Technologies2005-11-012015-12-29

Conditions studied

Pulmonary Disease, Chronic Obstructive (5)  ·  Respiratory Insufficiency (4)  ·  Asthma (1)  ·  Emphysema (1)  ·  Heart Failure (1)  ·  Respiratory Distress Syndrome (1)

Countries

United Kingdom (2)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  United States (1)

Top investigators

Felix JF Herth, MD (1)  ·  Jean-Luc Diehl (1)  ·  Luigi Camporota, PhD (1)  ·  Nausherwan Burki, MD, PhD (1)  ·  Nicholas Barrett, FCICM (1)  ·  Nicholas Hart, PhD (1)  ·  Nicholas Hill, MD (1)  ·  RK Mani, MD (1)  ·  Steven Tsui, MD (1)

Results publications

PMID 23460154, PMID 31362776, PMID 31928313, PMID 32990836, PMID 33854019, PMID 35445986, PMID 38261630, PMID 39639560